ZIMMER BIOMET HOLDINGS, INC. (ZBH) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | Gross Profit |
| Revenue | 8.51B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 2.56B USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $8.51B | $2.56B | (m) |
| 2026-03-31 | (m) | $8.41B | $2.52B | (m) |
| 2025-12-31 | (m) | $8.23B | $2.49B | (m) |
| 2025-09-30 | (m) | $8.01B | $2.29B | (m) |
| 2025-06-30 | (m) | $7.83B | $2.27B | (m) |
| 2025-03-31 | (m) | $7.70B | $2.23B | (m) |
| 2024-12-31 | (m) | $7.68B | $2.19B | (m) |
| 2024-09-30 | (m) | $7.60B | $2.14B | (m) |
| 2024-06-30 | (m) | $7.52B | $2.12B | (m) |
| 2024-03-31 | (m) | $7.45B | $2.10B | (m) |
| 2023-12-31 | (m) | $7.39B | $2.08B | (m) |
| 2023-09-30 | (m) | $7.28B | $2.07B | (m) |
| 2023-06-30 | (m) | $7.20B | $2.03B | (m) |
| 2023-03-31 | (m) | $7.11B | $2.02B | (m) |
| 2022-12-31 | (m) | $6.94B | $2.02B | (m) |
| 2022-09-30 | (m) | $6.89B | $2.04B | (m) |
| 2022-06-30 | (m) | $6.91B | $2.04B | (m) |
| 2022-03-31 | (m) | $7.90B | $2.40B | (m) |
| 2021-12-31 | (m) | $7.84B | $2.34B | (m) |
| 2021-09-30 | (m) | $7.88B | $2.33B | (m) |
| 2021-06-30 | (m) | $7.89B | $2.31B | (m) |
| 2021-03-31 | (m) | $7.09B | $2.16B | (m) |
| 2020-12-31 | (m) | $7.02B | $2.13B | (m) |
| 2020-09-30 | (m) | $7.06B | $2.06B | (m) |
| 2020-06-30 | (m) | $7.03B | $2.03B | (m) |
| 2020-03-31 | (m) | $7.79B | $2.19B | (m) |
| 2019-12-31 | $5.15B | $7.98B | $2.25B | 64.46% |
| 2019-09-30 | (m) | $7.93B | $2.25B | (m) |
| 2019-06-30 | (m) | $7.87B | $2.25B | (m) |
| 2019-03-31 | (m) | $7.89B | $2.25B | (m) |
| 2018-12-31 | $5.07B | $7.93B | $2.27B | 63.85% |
| 2018-09-30 | (m) | (m) | (m) | (m) |
| 2018-06-30 | $5.05B | $7.91B | (m) | 63.87% |
| 2018-03-31 | $5.05B | $7.85B | (m) | 64.34% |
| 2017-12-31 | $5.09B | (m) | (m) | (m) |
| 2017-09-30 | $5.01B | (m) | (m) | (m) |
| 2017-06-30 | $5.03B | (m) | (m) | (m) |
| 2017-03-31 | $4.91B | (m) | (m) | (m) |
| 2016-12-31 | $4.74B | (m) | (m) | (m) |
| 2016-09-30 | $4.59B | (m) | (m) | (m) |
| 2016-06-30 | $4.49B | (m) | (m) | (m) |
| 2016-03-31 | $4.17B | (m) | (m) | (m) |
| 2015-12-31 | $3.86B | (m) | (m) | (m) |
| 2015-09-30 | $3.65B | (m) | (m) | (m) |
| 2015-06-30 | $3.45B | (m) | (m) | (m) |
| 2015-03-31 | $3.42B | (m) | (m) | (m) |
| 2014-12-31 | $3.42B | (m) | (m) | (m) |
| 2014-09-30 | $3.41B | (m) | (m) | (m) |
| 2014-06-30 | $3.35B | (m) | (m) | (m) |
| 2014-03-31 | $3.35B | (m) | (m) | (m) |
| 2013-12-31 | $3.34B | (m) | (m) | (m) |
| 2013-09-30 | $3.32B | (m) | (m) | (m) |
| 2013-06-30 | $3.34B | (m) | (m) | (m) |
| 2013-03-31 | $3.34B | (m) | (m) | (m) |
| 2012-12-31 | $3.35B | (m) | (m) | (m) |
| 2012-09-30 | $3.33B | (m) | (m) | (m) |
| 2012-06-30 | $3.34B | (m) | (m) | (m) |
| 2012-03-31 | $3.35B | (m) | (m) | (m) |
| 2011-12-31 | $3.33B | (m) | (m) | (m) |
| 2011-09-30 | $3.33B | (m) | (m) | (m) |
| 2011-06-30 | $3.29B | (m) | (m) | (m) |
| 2011-03-31 | $3.25B | $4.27B | $1.02B | 76.06% |
| 2010-12-31 | $3.21B | $4.22B | $1.01B | 76.01% |
| 2010-09-30 | $3.18B | $4.19B | $1.01B | 75.85% |
| 2010-06-30 | $3.16B | $4.20B | $1.04B | 75.19% |
| 2010-03-31 | $3.14B | $4.17B | $1.03B | 75.30% |
| 2009-12-31 | $3.10B | $4.10B | $990.80M | 75.81% |
| 2009-09-30 | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) |
| 2008-12-31 | $3.12B | $4.12B | $997.30M | 75.80% |
| 2008-09-30 | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) |
| 2007-12-31 | $3.02B | $3.90B | $875.90M | 77.53% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |